18 results on '"Nappi, C"'
Search Results
2. POSC237 The Monitoring of Prescription Appropriateness for Achieving the Objectives of Pharmaceutical Spending and Providing Essential Levels of Assistance
3. P68 Cardiovascular Events and Mortality in Type-2 Diabetic Patients under Second-Line Treatment with Hypoglycemic Agents: An Italian Real-World Study
4. POSA239 Impact of AIFA Note 96 on Vitamin D Analogs' Prescriptive Appropriateness
5. POSA310 Artificial Intelligence Applied on Administrative Big Data to Predict the Severity of SARS-COV-2 Infection
6. PUK22 Real-World Analysis of Incidence Rates of Clinical Events on Patients with Chronic Kidney Disease with and without Secondary Hyperparathyroidism in Italy
7. Cost-Effectiveness Analysis Of Daclatasvir/Sofosbuvir (DCV/SOF) For The Treatment Of HCV Patients Who Failed After First Line Treatment With Second Generation Of Daa In Italy
8. Therapeutic Strategies Utilization and Resources Consumption in Patients Treated for Psoriatic Arthritis in Italy
9. Epidemiology of Hepatitis C Patients In Italian Local Health Units (Lhus)
10. Cost-Effectiveness of Abatacept Compared to Adalimumab In Italy Based on A Head-To-Head Outcomes Study In Rheumatoid Arthritis
11. Budget Impact Analysis of The Use of Daclatasvir for The Treatment of Hepatitis C Virus (Hcv) Genotypes 3, In The Italian Setting
12. Cost Effectiveness Analysis of The Use of Daclatasvir for the Treatment of Hepatitis C Virus (Hcv) Genotypes 3 in Cirrhotic Patients Within the Italian National Health Service
13. PIN51 - Cost-Effectiveness Analysis Of Daclatasvir/Sofosbuvir (DCV/SOF) For The Treatment Of HCV Patients Who Failed After First Line Treatment With Second Generation Of Daa In Italy
14. PMS59 - Therapeutic Strategies Utilization and Resources Consumption in Patients Treated for Psoriatic Arthritis in Italy
15. PMS58 - Cost-Effectiveness of Abatacept Compared to Adalimumab In Italy Based on A Head-To-Head Outcomes Study In Rheumatoid Arthritis
16. PIN25 - Budget Impact Analysis of The Use of Daclatasvir for The Treatment of Hepatitis C Virus (Hcv) Genotypes 3, In The Italian Setting
17. PIN18 - Epidemiology of Hepatitis C Patients In Italian Local Health Units (Lhus)
18. PIN65 - Cost Effectiveness Analysis of The Use of Daclatasvir for the Treatment of Hepatitis C Virus (Hcv) Genotypes 3 in Cirrhotic Patients Within the Italian National Health Service
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.